The global orthopedic digit implants market size was estimated at USD 283.44 million in 2024 and is projected to reach USD 488.89 million by 2033, growing at a CAGR of 6.17% from 2025 to 2033. The rising prevalence of orthopedic conditions such as rheumatoid arthritis and osteoarthritis is expected to drive market growth.
This trend, coupled with an aging population and increasing demand for joint preservation solutions, is fueling the adoption of advanced orthopedic implants. In February 2025, SingleCare reported that nearly 1 in 4 American adults has arthritis, with osteoarthritis being the most common form. The article highlights that more than 33 million U.S. adults are affected by osteoarthritis, and the economic burden exceeds USD 300 billion annually. Arthritis is also a leading cause of work limitations in the U.S., with 25.7 million adults experiencing physical restrictions. Increasing technological advancements in orthopedic implants including orthopedic digit implants is anticipated to accelerate market growth. Advanced biomaterials with better biocompatibility and durability have improved the quality of implants, leading to an increase in their demand. These biomaterials consist of ceramics and alloys that imitate the properties of natural bone and joints, which has further contributed to market growth. The use of computer-aided design and biomechanics studies has also played a significant role in the development of precise implant designs, further boosting the market growth. In March 2024, OrthoVentions LLC made an investment in MotioOV, which is an early-stage company that was created in partnership with the Hospital for Special Surgery (HSS). MotioOV's focus is to develop a unique 3D printed implant as well as custom instruments that can help address issues related to stiffness and pain caused by arthritis of the first metatarsophalangeal (MTP) joint.
Increasing demand for minimally invasive procedures drives the demand for orthopedic digit implants. The increasing adoption of organic and inorganic strategies by the key market players is expected to spur market growth. For instance, in January 2024, Extremity Medical LLC, a medical engineering firm, has announced a strategic relationship with Henry Schein, Inc., a global healthcare solutions company. This partnership will help Extremity Medical expand its innovative orthopedic extremity implant systems. In addition, the company completed growth debt financing from June through November, which will help fuel its growth. Such initiatives undertaken by market players will foster market growth.
The orthopedic industry is expected to experience rapid growth due to the increasing number of new players entering the market. In April 2024, Henry Schein, Inc., the largest provider of healthcare solutions for dental and medical practitioners, announced the completion of its acquisition of TriMed, Inc. TriMed is a global developer of orthopedic solutions for the treatment of upper extremities like hands and wrists, and lower extremities like feet and ankles. Henry Schein had announced its intention to acquire a majority interest in TriMed on December 20, 2023. With this acquisition, Henry Schein entered the market for orthopedic extremities.
Increasing government and non-government initiatives escalate the market growth. For instance, in June 2022, Loci Orthopaedics, a Medtech start-up, received USD 8 million in funding and financial support from the European Commission's European Innovation Council (EIC) Accelerator Programme. The grant and equity investment will be utilized to conduct a clinical trial of the company's implant treatment for thumb arthritis, before proceeding to full-scale commercialization.
This product will be delivered within 1-3 business days.
This trend, coupled with an aging population and increasing demand for joint preservation solutions, is fueling the adoption of advanced orthopedic implants. In February 2025, SingleCare reported that nearly 1 in 4 American adults has arthritis, with osteoarthritis being the most common form. The article highlights that more than 33 million U.S. adults are affected by osteoarthritis, and the economic burden exceeds USD 300 billion annually. Arthritis is also a leading cause of work limitations in the U.S., with 25.7 million adults experiencing physical restrictions. Increasing technological advancements in orthopedic implants including orthopedic digit implants is anticipated to accelerate market growth. Advanced biomaterials with better biocompatibility and durability have improved the quality of implants, leading to an increase in their demand. These biomaterials consist of ceramics and alloys that imitate the properties of natural bone and joints, which has further contributed to market growth. The use of computer-aided design and biomechanics studies has also played a significant role in the development of precise implant designs, further boosting the market growth. In March 2024, OrthoVentions LLC made an investment in MotioOV, which is an early-stage company that was created in partnership with the Hospital for Special Surgery (HSS). MotioOV's focus is to develop a unique 3D printed implant as well as custom instruments that can help address issues related to stiffness and pain caused by arthritis of the first metatarsophalangeal (MTP) joint.
Increasing demand for minimally invasive procedures drives the demand for orthopedic digit implants. The increasing adoption of organic and inorganic strategies by the key market players is expected to spur market growth. For instance, in January 2024, Extremity Medical LLC, a medical engineering firm, has announced a strategic relationship with Henry Schein, Inc., a global healthcare solutions company. This partnership will help Extremity Medical expand its innovative orthopedic extremity implant systems. In addition, the company completed growth debt financing from June through November, which will help fuel its growth. Such initiatives undertaken by market players will foster market growth.
The orthopedic industry is expected to experience rapid growth due to the increasing number of new players entering the market. In April 2024, Henry Schein, Inc., the largest provider of healthcare solutions for dental and medical practitioners, announced the completion of its acquisition of TriMed, Inc. TriMed is a global developer of orthopedic solutions for the treatment of upper extremities like hands and wrists, and lower extremities like feet and ankles. Henry Schein had announced its intention to acquire a majority interest in TriMed on December 20, 2023. With this acquisition, Henry Schein entered the market for orthopedic extremities.
Increasing government and non-government initiatives escalate the market growth. For instance, in June 2022, Loci Orthopaedics, a Medtech start-up, received USD 8 million in funding and financial support from the European Commission's European Innovation Council (EIC) Accelerator Programme. The grant and equity investment will be utilized to conduct a clinical trial of the company's implant treatment for thumb arthritis, before proceeding to full-scale commercialization.
Global Orthopedic Digit Implants Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global orthopedic digit implants market report based on product, material, end use, and region:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Metatarsal joint implants
- Metacarpal joint implants
- Hemi phalangeal implants
- Scaphoid bone implants
- Toe intramedullary implants
Material Outlook (Revenue, USD Million, 2021 - 2033)
- Titanium
- Nitinol
- Silicon pyrocarbon
- Stainless steel
- Other materials
End Use Outlook (Revenue USD Million, 2021 - 2033)
- Hospitals
- Outpatient Facilities
Regional Outlook Revenue USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- Spain
- Italy
- France
- Denmark
- Norway
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Orthopedic Digit Implants Market Variables, Trends & Scope
Chapter 4. Orthopedic Digit Implants Market Segment Analysis, By Product, 2021 - 2033 (USD Million)
Chapter 5. Orthopedic Digit Implants Market Segment Analysis, By Material, 2021 - 2033 (USD Million)
Chapter 6. Orthopedic Digit Implants Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
Chapter 7. Orthopedic Digit Implants Market Segment Analysis, By Region, By Product, By Material, By End Use, 2021- 2033 (USD Million)
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Extremity Medical LLC
- Stryker
- Zimmer
- Smith & Nephew
- Depuy
- Arthrex Inc
- Acumed LLC
- Anika Therapeutics, Inc.
- VILEX, LLC
- Paragon 28
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | July 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 283.44 Million |
| Forecasted Market Value ( USD | $ 488.89 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
